Scailyte is kicking off its new fundraising campaign! We are seeking like-minded investors who share our vision of a data-driven health future at single-cell resolution, where prevention and precision healthcare are driven by cutting-edge multi-omics data and AI.
Continue readingScailyte and Visterra Partner to Advance Autoimmune Disease Research
Scailyte AG, an AI-driven biomarker discovery company, and Visterra, Inc., a clinical-stage biopharmaceutical company, today announced a research collaboration with the goal to accelerate the development of innovative treatments for autoimmune diseases.
Continue readingPrecision Medicine and The Future of Genomics Summit 2024
Scailyte at the Global Stage of Precision Medicine – PMFG 2024! We are proud to share that our CEO, Peter Nestorov, will present at the Precision Medicine and the Future of Genomics Summit in Doha, Qatar. The summit will bring together global experts to shape the future of healthcare in the Middle East and beyond.
Continue readingExploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution
In this issue of ScaiDigest, we highlight two groundbreaking studies that expand the boundaries of immunotherapy research, focusing on the underestimated role of type 2 T cell immunity in cancer. Leveraging single-cell multi-omics, these studies illuminate how type 2 immunity, often overlooked in conventional paradigms, contributes to durable cancer remission and immune modulation. Together, they represent a paradigm shift in our understanding of T cell biology, underscoring the power of single-cell data to drive unbiased and transformative discoveries.
Continue readingGlobal Entrepreneurship Week Basel
Pitch Nic 2024 at Novartis Campus
We’re thrilled to announce that our CEO, Peter Nestorov will join the innovative minds at Pitch Nic on November 21 at the Novartis Campus, hosted by Switzerland Innovation Park Basel Area and DayOne. This invitation-only event brings together pioneering healthtech startups to showcase cutting-edge innovations shaping the future of healthcare.
Continue readingGenomics for Health 2024
Don’t miss Scailyte’s CEO, Peter Nestorov, at the Genomics for Health 2024 event, bridging cutting-edge science and leading industry.
Continue readingThe Year of the AI Nobel
2024 is being hailed as the “Year of the AI Nobel,” marking a milestone as artificial intelligence (AI) researchers received Nobel Prizes across both Physics and Chemistry.
Continue readingLife Science Industry Meets Data Science Symposium
Scailyte is thrilled to be part of the LIFE SCIENCE INDUSTRY MEETS DATA SCIENCE symposium organised by CSEM and Bio-Techne, where cutting-edge innovations are taking center stage. This event is set to redefine how data-driven solutions are revolutionizing the life science sector, from bioprocesses to biopharma and health.
Continue readingWorld CB & CDx Summit 2024
Scailyte is thrilled to attend Hanson Wade’s 14th World CB & CDx Summit – the flagship CDx event of the year in Boston, September 3-6!
Continue reading